Joyce O'Shaughnessy

Joyce O'Shaughnessy at Baylor University Medical Center is one of the most influential breast cancer clinician-researchers in the world, with particular expertise in triple-negative breast cancer. She has contributed to pivotal trials of sacituzumab govitecan (ASCENT) and numerous chemotherapy regimens for TNBC. Her research spans metastatic disease management, novel ADC combinations, and quality-of-life optimization for patients with TNBC. She has shaped NCCN guidelines and has mentored numerous breast cancer investigators.